| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 217.75B | 212.34B | 196.62B | 184.03B | 170.32B |
| Gross Profit | 48.25B | 44.89B | 35.86B | 29.68B | 30.64B |
| EBITDA | 28.91B | 27.01B | 22.70B | 15.62B | 17.64B |
| Net Income | 20.66B | 12.20B | 10.28B | 6.87B | 6.12B |
Balance Sheet | |||||
| Total Assets | 226.08B | 209.82B | 192.68B | 180.00B | 164.65B |
| Cash, Cash Equivalents and Short-Term Investments | 35.80B | 34.39B | 22.81B | 22.03B | 25.86B |
| Total Debt | 10.55B | 9.74B | 6.78B | 11.96B | 12.03B |
| Total Liabilities | 64.81B | 64.55B | 60.54B | 59.43B | 55.15B |
| Stockholders Equity | 161.26B | 145.27B | 132.14B | 120.57B | 109.49B |
Cash Flow | |||||
| Free Cash Flow | 4.57B | 14.69B | 13.86B | -2.88B | 3.35B |
| Operating Cash Flow | 21.55B | 21.34B | 19.93B | 8.27B | 14.02B |
| Investing Cash Flow | -12.48B | -12.46B | -10.57B | -11.01B | -7.80B |
| Financing Cash Flow | -4.36B | -3.42B | -4.34B | -5.79B | -4.83B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥143.18B | 20.48 | 10.46% | 2.35% | 2.55% | 72.25% | |
76 Outperform | ¥537.76B | 9.78 | 6.90% | 2.71% | 4.41% | 176.65% | |
74 Outperform | ¥78.67B | 21.16 | ― | 6.64% | 2.45% | 1.87% | |
70 Outperform | ¥13.14B | 10.20 | ― | 1.20% | 1.06% | -1.71% | |
63 Neutral | ¥96.87B | 12.05 | 7.53% | 3.01% | 5.17% | 20.88% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥18.38B | 7.18 | ― | 4.39% | 1.59% | -5.58% |